STAT3 and fatty liver disease: Interestingly, the PPARG agonist Lobe mitigates hepatic steatosis and preadipocyte differentiation induced by STAT3 inactivation, highlighting the role of STAT3 in regulating lipid metabolism via PPARG [24,25].